Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II

• Main Authors: Enrico Torre (Author), Giacomo Matteo Bruno (Author), Sergio Di Matteo (Author), Chiara Martinotti (Author), Maria Chiara Valentino (Author), Luigi Carlo Bottaro (Author), Giorgio Lorenzo Colombo (Author)
• Format: Book
• Published: SAGE Publishing, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetes treatment cost represents an ever-growing problem. The adoption of new drugs in therapy, although they can guarantee an improvement in patient's quality of life, can meet obstacles when it involves an increase in costs. We decided to compare the costs and benefits of the new saxaglipti...